Evidence map›Paper›PMID 25224745›Full record

ArticleBiochimica et biophysica acta2014

Copper binding affinity of the C2B domain of synaptotagmin-1 and its potential role in the nonclassical secretion of acidic fibroblast growth factor.

Srinivas Jayanthi, Karuppanan Muthusamy Kathir, Dakshinamurthy Rajalingam, Mercede Furr, Anna Daily, Ryan Thurman, Lindsay Rutherford, Reena Chandrashekar, Paul Adams, Igor Prudovsky and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Srinivas JayanthiDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: sjayanth@uark.edu.
Karuppanan Muthusamy KathirDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: kmkathir@gmail.com.
Dakshinamurthy RajalingamDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: rajalingam.dakshinamurthy@wku.edu.
Mercede FurrDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: mfurr@email.uark.edu.
Anna DailyDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: dailyphd@gmail.com.
Ryan ThurmanDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: rdt001@uark.edu.
Lindsay RutherfordDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: lnrutherford@gmail.com.
Reena ChandrashekarDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: rxc018@uark.edu.
Paul AdamsDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: pxa001@uark.edu.
Igor PrudovskyMaine Medical Center Research Institute, Scarborough, ME 04074, USA. Electronic address: prudoi@mmc.org.
Thallapuranam Krishnaswamy Suresh KumarDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, USA. Electronic address: sthalla@uark.edu.
University of Arkansas at Fayetteville · USMaine Medical Center · US

Funding

Structure based drug discoveryP20RR015569 · NCRR · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2000 to 2009
$21.4M
Phase III COBRE in Vascular BiologyP30GM103392 · NIGMS · MAINEHEALTH · PI ST. GERMAIN, DONALD L. · 2012 to 2016
$4.7M
Center for Protein Structure and FunctionP30GM103450 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2012 to 2014
$3.2M
THE PATHOLOGY OF HUMAN ENDOTHELIAL CELL PHENOTYPESR01HL035627 · NHLBI · MELOY LABORATORIES, INC. · PI PRUDOVSKY, IGOR · 1985 to 2010
$2.3M
Biophysical studies of oncogenic Cdc42Hs constructsK01CA113753 · NCI · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI ADAMS, PAUL DAMIEN · 2007 to 2011
$769k
NCI NIH HHS K01 CA113753NCRR NIH HHS P20 RR015569NHLBI NIH HHS R01 HL035627NIGMS NIH HHS P30 GM103392NIGMS NIH HHS P30 GM103450
6 · The paper itself

Abstract

Fibroblast growth factor 1 (FGF1) is a heparin-binding proangiogenic protein. FGF1 lacks the conventional N-terminal signal peptide required for secretion through the endoplasmic reticulum (ER)-Golgi secretory pathway. FGF1 is released through a Cu(2+)-mediated nonclassical secretion pathway. The secretion of FGF1 involves the formation of a Cu(2+)-mediated multiprotein release complex (MRC) including FGF1, S100A13 (a calcium-binding protein) and p40 synaptotagmin (Syt1). It is believed that the binding of Cu(2+) to the C2B domain is important for the release of FGF1 into the extracellular medium. In this study, using a variety of biophysical studies, Cu(2+) and lipid interactions of the C2B domain of Syt1 were characterized. Isothermal titration calorimetry (ITC) experiments reveal that the C2B domain binds to Cu(2+) in a biphasic manner involving an initial endothermic and a subsequent exothermic phase. Fluorescence energy transfer experiments using Tb(3+) show that there are two Cu(2+)-binding pockets on the C2B domain, and one of these is also a Ca(2+)-binding site. Lipid-binding studies using ITC demonstrate that the C2B domain preferentially binds to small unilamellar vesicles of phosphatidyl serine (PS). Results of the differential scanning calorimetry and limited trypsin digestion experiments suggest that the C2B domain is marginally destabilized upon binding to PS vesicles. These results, for the first time, suggest that the main role of the C2B domain of Syt1 is to serve as an anchor for the FGF1 MRC on the membrane bilayer. In addition, the binding of the C2B domain to the lipid bilayer is shown to significantly decrease the binding affinity of the protein to Cu(2+). The study provides valuable insights on the sequence of structural events that occur in the nonclassical secretion of FGF1.

Indexed as

Fibroblast growth factorLipid bindingNonclassicalSecretionSignal peptideSynaptotagmin

Identifiers

PMID25224745
PMCPMC4362929
OpenAlexW2015109246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.